Abstract

This systematic review aims to evaluate the efficacy and safety of acupuncture therapy for treating patients with chondromalacia patellae compared to non-steroidal anti-inflammatory drugs (NSAID). Eight databases including PubMed, EMBASE, CENTRAL, ISI Web of Science, CNKI, Wanfang, VIP, and CBM were searched up to June 2016. Randomized controlled trials (RCT) assessing the efficacy of acupuncture therapy were identified. The patients in experimental groups had to be treated with acupuncture therapy, and the patients in control groups had to be treated with NSAID. The outcome measures included clinical efficacy rates or pain scores. A total of 7 studies met our inclusion criteria. We analyzed the data from these 7 RCT involving 707 participants. All included studies were judged to be at high risk for bias. Compared with NSAID, acupuncture could further improve the clinical efficacy rates (Risk Ratio 2.57; 95% confidence interval (CI) 2.02, 3.27) and pain scores (Mean Difference -1.49; 95% CI -2.37, -0.62). No study reported adverse events associated with acupuncture therapy. Based on the findings in the present review, acupuncture therapy is more effective than NSAID in improving clinical efficacy rates and pain scores. However, these results should be interpreted cautiously due to the poor overall methodological quality of the included trials. Additional studies with large-scale and rigorous experimental design are required.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.